CEO
Oliver Peoples
Employees
43
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
Loading...
Open
0.69
Mkt cap
405K
Volume
2K
High
0.69
P/E Ratio
-0.03
52-wk high
17.28
Low
0.58
Div yield
N/A
52-wk low
0.53
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 12:47 pm
Portfolio Pulse from Benzinga Insights
April 15, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
April 10, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
April 02, 2024 | 5:23 pm
Portfolio Pulse from Benzinga Insights
April 02, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
April 02, 2024 | 3:39 pm
Portfolio Pulse from Benzinga Insights
April 01, 2024 | 8:25 pm
Portfolio Pulse from dijoy@benzinga.com
April 01, 2024 | 8:23 pm
Portfolio Pulse from Benzinga Insights
April 01, 2024 | 9:13 am
Portfolio Pulse from Benzinga Insights
March 29, 2024 | 12:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.